GERN Valuation

Geron Corp

Add to Watchlist

Advanced Chart

1.330

+0.01(0.758%)1D

Overview
Forecast
Valuation
Earnings

GERN Relative Valuation

GERN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GERN is overvalued; if below, it's undervalued.

Historical Valuation

Geron Corp (GERN) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.21 is considered Undervalued compared with the five-year average of -8.83. The fair price of Geron Corp (GERN) is between 12.56 to 15.12 according to relative valuation methord. Compared to the current price of 1.33 USD , Geron Corp is Undervalued By 89.39%.

Relative Value

Fair Zone

12.56-15.12

Current Price：1.33

89.39%

Undervalued

-13.94

Trailing

Forward

-7.36

EV/EBITDA

Geron Corp. (GERN) has a current EV/EBITDA of -7.36. The 5-year average EV/EBITDA is -4.25. The thresholds are as follows: Strongly Undervalued below -47.43, Undervalued between -47.43 and -25.84, Fairly Valued between 17.35 and -25.84, Overvalued between 17.35 and 38.94, and Strongly Overvalued above 38.94. The current Forward EV/EBITDA of -7.36 falls within the Historic Trend Line -Fairly Valued range.

-8.82

EV/EBIT

Geron Corp. (GERN) has a current EV/EBIT of -8.82. The 5-year average EV/EBIT is -5.93. The thresholds are as follows: Strongly Undervalued below -15.88, Undervalued between -15.88 and -10.90, Fairly Valued between -0.96 and -10.90, Overvalued between -0.96 and 4.02, and Strongly Overvalued above 4.02. The current Forward EV/EBIT of -8.82 falls within the Historic Trend Line -Fairly Valued range.

3.21

Geron Corp. (GERN) has a current PS of 3.21. The 5-year average PS is 1337.17. The thresholds are as follows: Strongly Undervalued below -1816.33, Undervalued between -1816.33 and -239.58, Fairly Valued between 2913.92 and -239.58, Overvalued between 2913.92 and 4490.68, and Strongly Overvalued above 4490.68. The current Forward PS of 3.21 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Geron Corp. (GERN) has a current P/OCF of 0.00. The 5-year average P/OCF is -3.41. The thresholds are as follows: Strongly Undervalued below -14.63, Undervalued between -14.63 and -9.02, Fairly Valued between 2.21 and -9.02, Overvalued between 2.21 and 7.82, and Strongly Overvalued above 7.82. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-120.31

P/FCF

Geron Corp. (GERN) has a current P/FCF of -120.31. The 5-year average P/FCF is -12.39. The thresholds are as follows: Strongly Undervalued below -59.75, Undervalued between -59.75 and -36.07, Fairly Valued between 11.30 and -36.07, Overvalued between 11.30 and 34.98, and Strongly Overvalued above 34.98. The current Forward P/FCF of -120.31 falls within the Strongly Undervalued range.

Geron Corp (GERN) has a current Price-to-Book (P/B) ratio of 3.24. Compared to its 3-year average P/B ratio of 6.29 , the current P/B ratio is approximately -48.39% higher. Relative to its 5-year average P/B ratio of 5.06, the current P/B ratio is about -35.85% higher. Geron Corp (GERN) has a Forward Free Cash Flow (FCF) yield of approximately -21.17%. Compared to its 3-year average FCF yield of -13.00%, the current FCF yield is approximately 62.79% lower. Relative to its 5-year average FCF yield of -14.56% , the current FCF yield is about 45.37% lower.

3.27

P/B

Median3y

6.29

Median5y

5.06

-21.17

FCF Yield

Median3y

-13.00

Median5y

-14.56

Competitors Valuation Multiple

The average P/S ratio for GERN's competitors is , providing a benchmark for relative valuation. Geron Corp Corp (GERN) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 5459.64%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Tango Therapeutics Inc

Performance Decomposition

Market capitalization of GERN decreased by 70.70% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 882.00K to 49.04M.

The secondary factor is the Margin Expansion, contributed -99.56%to the performance.

Overall, the performance of GERN in the past 1 year is driven by Revenue Growth. Which is more sustainable.

5459.64%

882.00K → 49.04M

Revenue Growth

-99.56%

-7.64K → -33.39

Margin Expansion

-5430.78%

0.19 → -10.05

P/E Change

-70.70%